Literature DB >> 10597279

Nuclear 24 kD fibroblast growth factor (FGF)-2 confers metastatic properties on rat bladder carcinoma cells.

M Okada-Ban1, G Moens, J P Thiery, J Jouanneau.   

Abstract

The tumorigenic and metastatic properties of rat bladder carcinoma NBT-II cells transfected with a cDNA encoding the 24 kD nuclear isoform of human fibroblast growth factor-2 (FGF-2) were analysed and compared with those cells producing the 18 kD cytoplasmic isoform FGF-2. In transfected clones, 24 kD FGF-2 was found in the nucleus, and no FGF-2 was secreted. RT-PCR analysis showed no upregulation of FGF-2-specific receptor FGFR2c expression in these proliferating transfected cells. A shorter latency period for in vivo tumor formation and abundant spontaneous lung metastases were only seen if nuclear FGF-2-producing cells were injected subcutaneously into nude mice. Intravenous injection of 24 kD FGF-2-producing cells led to extensive experimental lung metastases whereas injection of control NBT-II cells or 18 kD FGF-2-producing cells did not. As FGF-2-producing cells have no specific FGF-2 receptors, our results suggest that the 24 kD FGF-2 has nuclear targets, and activates metastatic property of carcinoma cells via a mechanism other than the conventional FGF receptor-mediated signaling pathway.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10597279     DOI: 10.1038/sj.onc.1203092

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  8 in total

1.  Variants in genes belonging to the fibroblast growth factor family are associated with lower extremity amputation in non-Hispanic whites: Findings from the chronic renal insufficiency cohort study.

Authors:  Jayanta Gupta; Nandita Mitra; Raymond R Townsend; Michael Fischer; Jeffrey R Schelling; David J Margolis
Journal:  Wound Repair Regen       Date:  2016-06-20       Impact factor: 3.617

2.  The influence of FGF2 high molecular weight (HMW) isoforms in the development of cardiac ischemia-reperfusion injury.

Authors:  Siyun Liao; Janet R Bodmer; Mohamad Azhar; Gilbert Newman; J Douglas Coffin; Thomas Doetschman; Jo El J Schultz
Journal:  J Mol Cell Cardiol       Date:  2010-01-29       Impact factor: 5.000

Review 3.  High molecular weight FGF2: the biology of a nuclear growth factor.

Authors:  K Chlebova; V Bryja; P Dvorak; A Kozubik; W R Wilcox; P Krejci
Journal:  Cell Mol Life Sci       Date:  2009-01       Impact factor: 9.261

4.  Basic fibroblast growth factor impact on retinoblastoma progression and survival.

Authors:  Colleen M Cebulla; Maria-Elena Jockovich; Yolanda Piña; Hinda Boutrid; Armando Alegret; Amy Kulak; Abigail S Hackam; Sanjoy K Bhattacharya; William J Feuer; Timothy G Murray
Journal:  Invest Ophthalmol Vis Sci       Date:  2008-07-09       Impact factor: 4.799

5.  FGF2 mediates DNA repair in epidermoid carcinoma cells exposed to ionizing radiation.

Authors:  Mélanie Marie; Sophia Hafner; Sandra Moratille; Pierre Vaigot; Solène Mine; Odile Rigaud; Michèle T Martin
Journal:  Int J Radiat Biol       Date:  2012-07-20       Impact factor: 2.694

6.  Nuclear basic fibroblast growth factor regulates triple-negative breast cancer chemo-resistance.

Authors:  Shenduo Li; Sturgis Payne; Fang Wang; Peter Claus; Zuowei Su; Jeffrey Groth; Joseph Geradts; Gustaaf de Ridder; Rebeca Alvarez; Paul Kelly Marcom; Salvatore V Pizzo; Robin E Bachelder
Journal:  Breast Cancer Res       Date:  2015-07-04       Impact factor: 6.466

7.  Inhibition of RUNX2 transcriptional activity blocks the proliferation, migration and invasion of epithelial ovarian carcinoma cells.

Authors:  Zhi-Qiang Wang; Mamadou Keita; Magdalena Bachvarova; Stephane Gobeil; Chantale Morin; Marie Plante; Jean Gregoire; Marie-Claude Renaud; Alexandra Sebastianelli; Xuan Bich Trinh; Dimcho Bachvarov
Journal:  PLoS One       Date:  2013-10-04       Impact factor: 3.240

8.  Internal ribosome entry site of bFGF is the target of thalidomide for IMiDs development in multiple myeloma.

Authors:  I-Chia Lien; Lin-Yea Horng; Pei-Lun Hsu; Chia-Ling Wu; Hui-Ching Sung; Rong-Tsun Wu
Journal:  Genes Cancer       Date:  2014-03
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.